Screener
Supernus Pharmaceuticals SUPN Net debt
Discontinued — last reported Q1 '26
Net debt at other companies
Other financials
Where this comes from
Calculated from Supernus Pharmaceuticals’s reported figures.
The source filing: Supernus Pharmaceuticals’s 10-Q, filed May 5, 2026. Open the filing →
- Filed
- May 5, 2026, 4:15 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001356576-26-000022
FAQ
- What is Supernus Pharmaceuticals's net debt?
- Supernus Pharmaceuticals (SUPN) reported net debt of -$145.42M in Q1 2026.
- How has Supernus Pharmaceuticals's net debt changed year-over-year?
- Supernus Pharmaceuticals's net debt decreased by 74.1% year-over-year, from -$83.54M to -$145.42M.
- What is the long-term trend for Supernus Pharmaceuticals's net debt?
- Over 5 years (2020 to 2025), Supernus Pharmaceuticals's net debt has grown at a -17.2% compound annual growth rate (CAGR), from -$228.54M to -$88.92M.
- What does net debt mean?
- Total debt minus cash and equivalents at the quarter end. The debt that would remain if the company used all its cash to pay down borrowings.
Ask your AI about Supernus Pharmaceuticals's net debt.
Connect your AI assistant and see it in context, right in your chat.
Connect your AI
Claude